These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 14500988)

  • 1. Antioxidant treatment in Alzheimer's disease: current state.
    Gilgun-Sherki Y; Melamed E; Offen D
    J Mol Neurosci; 2003; 21(1):1-11. PubMed ID: 14500988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant therapy in acute central nervous system injury: current state.
    Gilgun-Sherki Y; Rosenbaum Z; Melamed E; Offen D
    Pharmacol Rev; 2002 Jun; 54(2):271-84. PubMed ID: 12037143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy.
    Gilgun-Sherki Y; Melamed E; Offen D
    J Neurol; 2004 Mar; 251(3):261-8. PubMed ID: 15015004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxidative stress in multiple sclerosis].
    Miller E; Mrowicka M; Zołyński K; Kedziora J
    Pol Merkur Lekarski; 2009 Dec; 27(162):499-502. PubMed ID: 20120717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
    Gugliandolo A; Bramanti P; Mazzon E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.
    Walia V; Kaushik D; Mittal V; Kumar K; Verma R; Parashar J; Akter R; Rahman MH; Bhatia S; Al-Harrasi A; Karthika C; Bhattacharya T; Chopra H; Ashraf GM
    Mol Neurobiol; 2022 Jan; 59(1):657-680. PubMed ID: 34751889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant pathways in Alzheimer's disease: possibilities of intervention.
    Viña J; Lloret A; Giraldo E; Badia MC; Alonso MD
    Curr Pharm Des; 2011 Dec; 17(35):3861-4. PubMed ID: 21933145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants and Alzheimer's disease: from bench to bedside (and back again).
    Rutten BP; Steinbusch HW; Korr H; Schmitz C
    Curr Opin Clin Nutr Metab Care; 2002 Nov; 5(6):645-51. PubMed ID: 12394639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants.
    Prasad KN; Bondy SC
    Curr Aging Sci; 2014; 7(2):77-90. PubMed ID: 25101711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease.
    Moneim AE
    Curr Alzheimer Res; 2015; 12(4):335-49. PubMed ID: 25817254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of reactive oxygen species in the progression of Alzheimer's disease.
    Bhatt S; Puli L; Patil CR
    Drug Discov Today; 2021 Mar; 26(3):794-803. PubMed ID: 33306995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants.
    Chakrabarti S; Sinha M; Thakurta IG; Banerjee P; Chattopadhyay M
    Curr Med Chem; 2013; 20(37):4648-64. PubMed ID: 23834172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
    Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
    Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for the detection of antioxidants which prevent age related diseases: a critical review with particular emphasis on human intervention studies.
    Hoelzl C; Bichler J; Ferk F; Simic T; Nersesyan A; Elbling L; Ehrlich V; Chakraborty A; Knasmüller S
    J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():49-64. PubMed ID: 16077190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease.
    Zana M; Janka Z; Kálmán J
    Neurobiol Aging; 2007 May; 28(5):648-76. PubMed ID: 16624449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative damage and Alzheimer's disease: are antioxidant therapies useful?
    Moreira PI; Smith MA; Zhu X; Honda K; Lee HG; Aliev G; Perry G
    Drug News Perspect; 2005; 18(1):13-9. PubMed ID: 15753972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier.
    Gilgun-Sherki Y; Melamed E; Offen D
    Neuropharmacology; 2001 Jun; 40(8):959-75. PubMed ID: 11406187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Expert Rev Neurother; 2015 Jan; 15(1):19-40. PubMed ID: 25243342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.